PET scans utilize radioactive tracers, typically a glucose analog labeled with a positron-emitting isotope, to visualize metabolic processes in the body.

PET scans rely on the detection of gamma rays emitted during the decay of positron-emitting isotopes, which are introduced into the body via a radioactive tracer.

Fluorine-18 is a widely used positron-emitting isotope in PET tracers due to its favorable half-life, allowing for sufficient time for tracer distribution and imaging.

PET scans are primarily used to evaluate metabolic activity in various tissues and organs, providing insights into physiological processes and disease states.

In a PET scan, a small amount of radioactive tracer is injected into the patient's bloodstream, allowing it to distribute throughout the body.

PET scans typically take around 30-60 minutes to complete, including the time for tracer uptake and imaging.

PET scans are non-invasive, allowing for repeated imaging without causing discomfort or harm to the patient.

PET scans involve the use of radioactive tracers, which expose patients to a small amount of radiation.

PET scans are used in oncology for various purposes, including detecting cancerous tumors, monitoring tumor response to therapy, assessing cancer recurrence, and evaluating metastasis.

PET scans provide functional information about metabolic processes, while CT scans provide detailed anatomical images of organs and tissues.

PET/CT scans combine the functional information from PET with the anatomical details from CT, providing a comprehensive view of both metabolic activity and anatomical structures.

PET scans are used in cardiology to assess blood flow and metabolism in the heart, aiding in the diagnosis and management of various cardiac conditions.

PET scans typically have a spatial resolution in the range of 1-2 mm, allowing for detailed visualization of metabolic processes at a relatively small scale.

PET scans typically exhibit high sensitivity, with values ranging from 80-90%, enabling the detection of even small changes in metabolic activity.

PET scans generally have a specificity in the range of 70-80%, indicating their ability to accurately distinguish between normal and abnormal metabolic activity.